Veterinary Vaccines Market: Faster Innovation and Better Relationship Management Key to Garner Higher Market Shares; Global Industry Analysis and Opportunity Assessment, 2016 – 2026
- REP-GB-409
- 2016-07-07
- Category: Healthcare, Pharmaceuticals and Medical devices
- 284 Pages
- Format:
Introduction
Veterinary vaccines is the most lucrative product segment of focus for veterinary drug manufacturers, followed closely by parasiticides. Given the preventive nature of veterinary healthcare, the veterinary vaccine market is estimated to witness considerable revenue traction over the coming years. With increasing incidence of food-borne zoonotic diseases, global animal production has reduced by 15%–20% a year. Growing pet animal adoption trend due to increasingly secluded lifestyles, ageing global population and increasing per capita income levels are factors promoting demand for companion animal vaccines. Effective harmonization of product development, registration and approval guidelines could reduce time-to-market for veterinary vaccines. This could benefit all key stakeholders in the veterinary vaccine value chain – governments, drug makers, distributors, farm owners and pet animal owners.
Market Value Forecast
In terms of value, the global veterinary vaccines market is anticipated to be valued at US$ 14,149 Mn by 2026, expanding at a moderate CAGR over the forecast period.
Market Dynamics
Growth of the global veterinary vaccines market is mainly driven by improving food security along with rising humanization of pets and adoption. Increasing foodborne and zoonotic diseases, improving public health through controlling contagious diseases such as avian influenza and rising humanization of pets and adoption are some factors excepted to drive overall growth of the veterinary vaccines market. Companies are adopting various strategies to sustain in the market and create a distinct value proposition for diverse consumer segments in order to offer cost-effective treatment for animals. This is in turn expected to drive growth of the veterinary vaccines market in developing regions.
The global veterinary vaccines market is expected to witness impressive growth over the forecast period. However, declining influence of veterinarians, gaps in epidemiological knowledge of certain virulent veterinary diseases and pitfalls in identifying and understanding antigen/immunogenic structures are factors expected to hamper revenue growth of the global veterinary vaccines market.
Segmentation by Product
The global veterinary vaccines market is segmented on the basis of product type into attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines and recombinant vaccines. Among the product type segments, attenuated live vaccines segment accounts for highest market share and is expected to expand at the CAGR of 7.5% between 2015 and 2024.
Segmentation by Disease Application Type
The global veterinary vaccines market is segmented on the basis of disease application types into anaplasmosis, canine parvovirus, foot & mouth disease, newcastle disease, distemper disease, influenza, porcine reproductive & respiratory syndrome (PRRS) and others. Among the disease application type segments, foot & mouth disease segment currently accounts for highest market share.
Segmentation by Animal Type
The global veterinary vaccines market is segmented on the basis of animal type as companion animals, livestock animals and equine. Companion animals segment comprises three sub-segments namely – canine, avian and feline. Livestock segment comprises five sub-segments namely, aquatic, bovine, porcine, ovine and poultry. Among the animal type segments, livestock animals segment is expected to witness relatively impressive growth during the forecast period.
Segmentation by Distribution Channel
The global veterinary vaccines market is segmented on the basis of distribution channel veterinary clinics, veterinary hospitals, veterinary research institute and retail pharmacies. Among the distribution channel segments, veterinary clinics segment accounts for highest market share, and is expected to register a CAGR of 7.1% between 2015 and 2024.
Key Regions
By region, the global veterinary vaccines market has been segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Middle East & Africa (MEA) and Japan.
Globally, in terms of revenue, North America has been estimated to account for largest share of 30.4% in 2016, followed by Western Europe. Meanwhile, revenue from the market in Asia Pacific excluding Japan (APEJ) is expected to expand at the highest CAGR of 9.1% over the forecast period.
Key Players
Key players in the global veterinary vaccines market include Merial, Zoetis, Elanco, Merck & Co. Inc., Boehringer Ingelheim GmbH )(BIVI), Bayer Pharma AG, Ceva, Verbac, Diamond Animal Healthcare (Heska) and Indian Immunological Ltd.
Majority of players operating in the veterinary vaccines market are focused on entering into collaborations and partnerships with local distributors and retailers in order to enhance their presence in markets in various countries across the globe. Moreover, collaborations and partnerships also enable these companies to increase visibility of their products in markets across the concerned regions. Besides, companies are focusing on improving their competitive capabilities to strengthen their market presence worldwide and expand customer base.
This Future Market Insights report examines the ‘Global Veterinary Vaccines Market’ for the period 2016–2026. The primary objective of the report is to offer updates, trends, drivers, restraints, volume and value forecasts and opportunities for manufacturers operating in the global veterinary vaccines market.
Global demand for veterinary vaccines is increasing as a result of improving food security, Improving public health through controlling contagious diseases such as avian influenza, Increasing foodborne and zoonotic diseases and Rising humanization of pets and adoption. Markets in developed economies are witnessing increasing demand for veterinary vaccines due to rising adoption of tried and tested products and the trend is expected to boost the overall demand for veterinary vaccines such as e attenuated live vaccines during the forecast period. To understand and assess the opportunities in this market, the report is categorically split into four sections, namely market analysis by product type, disease application type, animal type, distribution type and region. The report analyses the global veterinary vaccines market in terms of market value (US$ Mn).
The report starts with an overview of the veterinary vaccines market and its usage in various applications globally. In the same section, FMI covers the veterinary vaccines market performance in terms of revenue. This section includes FMI’s analysis of key trends, drivers and restraints from the supply and demand side perspective.
The next section of the report analyses the market based on product type and presents the forecast in terms of value for the next 10 years. Product types covered in the report include:
- Attenuated Live Vaccines Market
- Conjugate Vaccines Market
- Inactivated Vaccines Market
- Subunit Vaccines Market
- Toxoid Vaccines Market
- DNA Vaccines Market
- Recombinant Vaccines Market
The next section of the report analyses the market based on disease application type segments and presents the forecast in terms of value for the next ten years. The disease application type segments covered in the report include:
- Anaplasmosis
- Canine Parvovirus
- Foot and Mouth Disease
- New Castle Disease
- Distemper Disease
- Influenza
- Porcine Reproductive & Respiratory Syndrome (PRRS)
- Others
The next section of the report analyses the market based on animal type segments and presents the forecast in terms of value for the next ten years. The animal type segments covered in the report include:
-
Companion Animals
- Canine
- Avine
- Feline
-
Livestock Animals
- Aquatic
- Bovine
- Porcine
- Ovine
- Poultry
- Equine
The next section of the report analyses the market based on distribution channel segments and presents the forecast in terms of value for the next ten years. The distribution channel segments covered in the report include:
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Retail Pharmacies
Furthermore, the report analyses the market based on regions and presents the forecast in terms of value for the next ten years. Regions covered in the report include:
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia Pacific Excluding Japan
- Middle East & Africa (MEA)
- Japan
The forecast presented for the market assesses the total revenue generated in the veterinary vaccines market. When developing the forecast, the starting point involves sizing the current market, which forms the basis for the forecast of how the market is anticipated to take shape in the near future. Given the characteristics of market, we triangulated the outcome based on different analysis of the supply side, demand side and GDP growth rate. However, quantifying the market across aforementioned segments and regions is more a matter of quantifying expectations and identifying opportunities rather than rationalising them after the forecast has been completed.
In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global veterinary vaccines market.
As previously highlighted, the global veterinary vaccines market is split into various categories based on region, product type, animal type and application type and distribution channel type. All these segments or categories have been analyzed in terms of Basis Point Share (BPS) to understand the individual segments’ relative contribution to market growth. This detailed level of information is important for identification of various key trends in the global veterinary vaccines market.
Another key feature of this report is the analysis of the veterinary vaccines market by region and product type, animal type and application type and distribution channel type; and the market revenue forecast in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical in assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales perspective in the global veterinary vaccines market.
1. Executive Summary
2. Research Methodology
3. Assumptions & Acronyms Used
4. Definition and Taxonomy
4.1.Market Definition
4.2.Taxonomy
5. Market Dynamics
5.1.Introduction
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunity
5.1.4. Trends
5.1.5. Regulations
6. Overall Market Outlook
6.1.Section Summary
6.2.Global Veterinary Vaccines Market Forecast, 2015-2026
6.3.Introduction
6.3.1. Y-o-Y Growth Projection
6.3.2. Absolute $ Opportunity
7. Global Veterinary Vaccines Market Analysis, By Product Type
7.1. Introduction
7.1.1. Global Veterinary Vaccines Market Overview
7.1.2. Global Veterinary Vaccines Market Value Share, by Product Type
7.1.3. Global Veterinary Vaccines Market Attractiveness by Product Type
7.1.4. Y-o-Y Growth Comparison, By Product Type
7.2. Market Value Forecast, By Product Type
7.2.1. Attenuated Live Vaccines
7.2.1.1. Absolute $ Opportunity
7.2.1.2. Market Value Forecast
7.2.2. Inactivated Vaccines
7.2.2.1. Absolute $ Opportunity
7.2.2.2. Market Value Forecast
7.2.3. Subunit Vaccines
7.2.3.1. Absolute $ Opportunity
7.2.3.2. Market Value Forecast
7.2.4. Toxoid Vaccines
7.2.4.1. Absolute $ Opportunity
7.2.4.2. Market Value Forecast
7.2.5. DNA Vaccines
7.2.5.1. Absolute $ Opportunity
7.2.5.2. Market Value Forecast
7.2.6. Recombinant Vaccines
7.2.6.1. Absolute $ Opportunity
7.2.6.2. Market Value Forecast
7.3. Global Veterinary Vaccines Market Trends, by Product Type
8. Global Veterinary Vaccines Market Analysis, By Diseases
8.1. Introduction
8.1.1. Overview
8.1.2. Global Veterinary Vaccines Market Value Share, by Diseases
8.1.3. Global Veterinary Vaccines Market Attractiveness by Diseases
8.1.4. Y-o-Y Growth Comparison, By Diseases
8.2. Market Value Forecast, By Diseases
8.2.1. Anaplasmosis
8.2.1.1. Absolute $ Opportunity
8.2.1.2. Market Value Forecast
8.2.2. Canine Parvovirus
8.2.2.1. Absolute $ Opportunity
8.2.2.2. Market Value Forecast
8.2.3. Foot & Mouth Disease
8.2.3.1. Absolute $ Opportunity
8.2.3.2. Market Value Forecast
8.2.4. Newcastle Disease
8.2.4.1. Absolute $ Opportunity
8.2.4.2. Market Value Forecast
8.2.5. Distemper Disease
8.2.5.1. Absolute $ Opportunity
8.2.5.2. Market Value Forecast
8.2.6. Influenza Disease
8.2.6.1. Absolute $ Opportunity
8.2.6.2. Market Value Forecast
8.2.7. Porcine Reproductive & Respiratory Syndrome (PRRS) Disease
8.2.7.1. Absolute $ Opportunity
8.2.7.2. Market Value Forecast
8.2.8. Others Disease
8.2.8.1. Absolute $ Opportunity
8.2.8.2. Market Value Forecast
8.3. Global Veterinary Vaccines Market Trends, by Diseases
9. Global Veterinary Vaccines Market Analysis, By Species Type
9.1. Introduction
9.1.1. Overview
9.1.2. Global Veterinary Vaccines Market Value Share, by Species Type
9.1.3. Global Veterinary Vaccines Market Attractiveness By Species Type
9.1.4. Y-o-Y Growth Comparison, By Species Type
9.2. Market Value Forecast, By Species Type
9.2.1. Companion Animal
9.2.1.1. Market Value Forecast
9.2.1.1.1. Canine
9.2.1.1.2. Avian
9.2.1.1.3. Feline
9.2.2. Livestock Animals
9.2.2.1. Market Value Forecast
9.2.2.1.1. Aquatic
9.2.2.1.2. Bovine
9.2.2.1.3. Porcine
9.2.2.1.4. Ovine/Caprine
9.2.2.1.5. Poultry
9.2.3. Equine
9.2.3.1. Absolute $ Opportunity
9.2.3.2. Market Value Forecast
9.3. Global Veterinary Vaccines Market Trends, by Species Type
10. Global Veterinary Vaccines Market Analysis, By Distribution Channel
10.1. Introduction
10.1.1. Global Veterinary Vaccines Market Value Share, by Distribution Channel
10.1.2. Global Veterinary Vaccines Market Attractiveness by Distribution Channel
10.1.3. Y-o-Y Growth Comparison, By Distribution Channel
10.2. Market Value Forecast, By Distribution Channel
10.2.1. Veterinary Clinic Segment
10.2.1.1. Absolute $ Opportunity
10.2.1.2. Market Value Forecast
10.2.2. Veterinary Hospital Segment
10.2.2.1. Absolute $ Opportunity
10.2.2.2. Market Value Forecast
10.2.3. Veterinary Research Institute
10.2.3.1. Absolute $ Opportunity
10.2.3.2. Market Value Forecast
10.2.4. Retail Pharmacies
10.2.4.1. Absolute $ Opportunity
10.2.4.2. Market Value Forecast
10.3. Global Veterinary Vaccines Market Trends, by Distribution Channel
10.4. Global Veterinary Vaccines Market Trends, by Diseases
11. Global Veterinary Vaccines Market Analysis, By Region
11.1. Introduction
11.1.1. Global Veterinary Vaccines Market Value Share, by Region
11.1.2. Global Veterinary Vaccines Market Attractiveness by Region
11.2. Market Value Forecast, By Region
11.2.1. North America
11.2.2. Latin America
11.2.3. Western Europe
11.2.4. Eastern Europe
11.2.5. APEJ
11.2.6. Japan
11.2.7. MEA
12. North America Veterinary Vaccines Market Analysis
12.1. Introduction
12.1.1. North America Veterinary Vaccines Market Value Forecast and Y-o-Y Growth
12.1.2. North America Veterinary Vaccines Market Absolute $ Opportunity
12.1.3. Market Value Forecast
12.1.3.1. By Country
12.1.3.1.1. U.S.
12.1.3.1.2. Canada
12.1.3.2. By Product Type
12.1.3.2.1. Attenuated Live Vaccines
12.1.3.2.2. Conjugate Vaccines
12.1.3.2.3. Inactivated Vaccines
12.1.3.2.4. Subunit Vaccines
12.1.3.2.5. Toxoid Vaccines
12.1.3.2.6. DNA Vaccines
12.1.3.2.7. Recombinant Vaccines
12.1.3.3. By Diseases Type
12.1.3.3.1. Anaplasmosis
12.1.3.3.2. Canine Parvovirus
12.1.3.3.3. Foot & Mouth Disease
12.1.3.3.4. New Castle Disease
12.1.3.3.5. Distemper Disease
12.1.3.3.6. Influenza
12.1.3.3.7. Porcine Reproductive & Respiratory Syndrome (PRRS)
12.1.3.3.8. Others
12.1.3.4. By Distribution Channel
12.1.3.4.1. Veterinary Clinics
12.1.3.4.2. Veterinary Hospitals
12.1.3.4.3. Veterinary Research Institutes
12.1.3.4.4. Retail Pharmacies & Others
12.1.3.5. By Species Type
12.1.3.5.1. Companion Animals
12.1.3.5.1.1. Canine
12.1.3.5.1.2. Avian
12.1.3.5.1.3. Feline
12.1.3.5.2. Livestock Animals
12.1.3.5.2.1. Aquatic
12.1.3.5.2.2. Bovine
12.1.3.5.2.3. Porcine
12.1.3.5.2.4. Ovine/Caprine
12.1.3.5.2.5. Poultry
12.1.3.5.3. Equine
12.1.4. North America Veterinary Vaccines Market Attractiveness
12.1.4.1. By Country
12.1.4.2. By Product Type
12.1.4.3. By Diseases
12.1.4.4. By Distribution Channel
12.1.4.5. By Species Type
12.2. Drivers and Restraints Impact Analysis
13. Latin America Veterinary Vaccines Market Analysis
13.1. Introduction
13.1.1. Latin America Veterinary Vaccines Market Value Forecast and Y-o-Y Growth
13.1.2. Latin America Veterinary Vaccines Market Absolute $ Opportunity
13.1.3. Market Value Forecast
13.1.3.1. By Country
13.1.3.1.1 Argentina
13.1.3.1.2. Brazil
13.1.3.1.3. Mexico
13.1.3.1.4. Rest of Latin America
13.1.3.2. By Product Type
13.1.3.2.1. Attenuated Live Vaccines
13.1.3.2.2. Conjugate Vaccines
13.1.3.2.3. Inactivated Vaccines
13.1.3.2.4. Subunit Vaccines
13.1.3.2.5. Toxoid Vaccines
13.1.3.2.6. DNA Vaccines
13.1.3.2.7. Recombinant Vaccines
13.1.3.3. By Diseases Type
13.1.3.3.1. Anaplasmosis
13.1.3.3.2. Canine Parvovirus
13.1.3.3.3. Foot & Mouth Disease
13.1.3.3.4. New Castle Disease
13.1.3.3.5. Distemper Disease
13.1.3.3.6. Influenza
13.1.3.3.7. Porcine Reproductive & Respiratory Syndrome (PRRS)
13.1.3.3.8. Others
13.1.3.4. By Distribution Channel
13.1.3.4.1. Veterinary Clinics
13.1.3.4.2. Veterinary Hospitals
13.1.3.4.3. Veterinary Research Institutes
13.1.3.4.4. Retail Pharmacies & Others
13.1.3.5. By Species Type
13.1.3.5.1. Companion Animals
13.1.3.5.1.1. Canine
13.1.3.5.1.2. Avian
13.1.3.5.1.3. Feline
13.1.3.5.2. Livestock Animals
13.1.3.5.2.1. Aquatic
13.1.3.5.2.2. Bovine
13.1.3.5.2.3. Porcine
13.1.3.5.2.4. Ovine/Caprine
13.1.3.5.2.5. Poultry
13.1.3.5.3.Equine
13.1.4. Latin America Veterinary Vaccines Market Attractiveness
13.1.4.1. By Country
13.1.4.2. By Product Type
13.1.4.3. By Diseases
13.1.4.4. By Distribution Channel
13.1.4.5. By Species Type
13.2. Drivers and Restraints Impact Analysis
14. Western Europe Veterinary Vaccines Market Analysis
14.1. Introduction
14.1.1. Western Europe Veterinary Vaccines Market Value Forecast and Y-o-Y Growth
14.1.2. Western Europe Veterinary Vaccines Market Absolute $ Opportunity
14.1.3. Market Value Forecast
14.1.3.1. By Country
14.1.3.1.1. Germany
14.1.3.1.2. Italy
14.1.3.1.3. France
14.1.3.1.4. UK
14.1.3.1.5. Spain
14.1.3.1.6. NORDIC Countries
14.1.3.1.7. Benelux
14.1.3.1.8. Rest of Western Europe
14.1.3.2. By Product Type
14.1.3.2.1. Attenuated Live Vaccines
14.1.3.2.2. Conjugate Vaccines
14.1.3.2.3. Inactivated Vaccines
14.1.3.2.4. Subunit Vaccines
14.1.3.2.5. Toxoid Vaccines
14.1.3.2.6. DNA Vaccines
14.1.3.2.7. Recombinant Vaccines
14.1.3.3. By Diseases Type
14.1.3.3.1. Anaplasmosis
14.1.3.3.2. Canine Parvovirus
14.1.3.3.3. Foot & Mouth Disease
14.1.3.3.4. New Castle Disease
14.1.3.3.5. Distemper Disease
14.1.3.3.6. Influenza
14.1.3.3.7. Porcine Reproductive & Respiratory Syndrome (PRRS)
14.1.3.3.8. Others
14.1.3.4. By Distribution Channel
14.1.3.4.1. Veterinary Clinics
14.1.3.4.2. Veterinary Hospitals
14.1.3.4.3. Veterinary Research Institutes
14.1.3.4.4. Retail Pharmacies & Others
14.1.3.5. By Species Type
14.1.3.5.1. Companion Animals
14.1.3.5.1.1. Canine
14.1.3.5.1.2. Avian
14.1.3.5.1.3. Feline
14.1.3.5.2. Livestock Animals
14.1.3.5.2.1. Aquatic
14.1.3.5.2.2. Bovine
14.1.3.5.2.3. Porcine
14.1.3.5.2.4. Ovine/Caprine
14.1.3.5.2.5. Poultry
14.1.3.5.3. Equine
14.1.4. Western Europe Veterinary Vaccines Market Attractiveness
14.1.4.1. By Country
14.1.4.2. By Product Type
14.1.4.3. By Diseases
14.1.4.4. By Distribution Channel
14.1.4.5. By Species Type
14.2. Drivers and Restraints Impact Analysis
15. Eastern Europe Veterinary Vaccines Market Analysis
15.1. Introduction
15.1.1. Eastern Europe Veterinary Vaccines Market Value Forecast and Y-o-Y Growth
15.1.2. Eastern Europe Veterinary Vaccines Market Absolute $ Opportunity
15.1.3. Market Value Forecast
15.1.3.1. By Country
15.1.3.1.1. Russia
15.1.3.1.2. Poland
15.1.3.1.3. Rest of Eastern Europe
15.1.3.2. By Product Type
15.1.3.2.1. Attenuated Live Vaccines
15.1.3.2.2. Conjugate Vaccines
15.1.3.2.3. Inactivated Vaccines
15.1.3.2.4. Subunit Vaccines
15.1.3.2.5. Toxoid Vaccines
15.1.3.2.6. DNA Vaccines
15.1.3.2.7. Recombinant Vaccines
15.1.3.3. By Diseases Type
15.1.3.3.1. Anaplasmosis
15.1.3.3.2. Canine Parvovirus
15.1.3.3.3. Foot & Mouth Disease
15.1.3.3.4. New Castle Disease
15.1.3.3.5. Distemper Disease
15.1.3.3.6. Influenza
15.1.3.3.7. Porcine Reproductive & Respiratory Syndrome (PRRS)
15.1.3.3.8. Others
15.1.3.4. By Distribution Channel
15.1.3.4.1. Veterinary Clinics
15.1.3.4.2. Veterinary Hospitals
15.1.3.4.3. Veterinary Research Institutes
15.1.3.4.4. Retail Pharmacies & Others
15.1.3.5. By Species Type
15.1.3.5.1. Companion Animals
15.1.3.5.1.1. Canine
15.1.3.5.1.2. Avian
15.1.3.5.1.3. Feline
15.1.3.5.2. Livestock Animals
15.1.3.5.2.1. Aquatic
15.1.3.5.2.2. Bovine
15.1.3.5.2.3. Porcine
15.1.3.5.2.4. Ovine/Caprine
15.1.3.5.2.5. Poultry
15.1.3.5.3. Equine
15.1.4. Eastern Europe Veterinary Vaccines Market Attractiveness
15.1.4.1. By Country
15.1.4.2. By Product Type
15.1.4.3. By Diseases
15.1.4.4. By Distribution Channel
15.1.4.5. By Species Type
15.2. Drivers and Restraints Impact Analysis
16. APEJ Veterinary Vaccines Market Analysis
16.1. Introduction
16.1.1. APEJ Veterinary Vaccines Market Value Forecast and Y-o-Y Growth
16.1.2. APEJ Veterinary Vaccines Market Absolute $ Opportunity
16.1.3. Market Value Forecast
16.1.3.1. By Country
16.1.3.1.1. Greater China
16.1.3.1.2. India
16.1.3.1.3. ASEAN
16.1.3.1.4. Australia and NZ
16.1.3.1.5. Rest of APEJ
16.1.3.2. By Product Type
16.1.3.2.1. Attenuated Live Vaccines
16.1.3.2.2. Conjugate Vaccines
16.1.3.2.3. Inactivated Vaccines
16.1.3.2.4. Subunit Vaccines
16.1.3.2.5. Toxoid Vaccines
16.1.3.2.6. DNA Vaccines
16.1.3.2.7. Recombinant Vaccines
16.1.3.3. By Diseases Type
16.1.3.3.1. Anaplasmosis
16.1.3.3.2. Canine Parvovirus
16.1.3.3.3. Foot & Mouth Disease
16.1.3.3.4. New Castle Disease
16.1.3.3.5. Distemper Disease
16.1.3.3.6. Influenza
16.1.3.3.7. Porcine Reproductive & Respiratory Syndrome (PRRS)
16.1.3.3.8. Others
16.1.3.4. By Distribution Channel
16.1.3.4.1. Veterinary Clinics
16.1.3.4.2. Veterinary Hospitals
16.1.3.4.3. Veterinary Research Institutes
16.1.3.4.4. Retail Pharmacies & Others
16.1.3.5. By Species Type
16.1.3.5.1. Companion Animals
16.1.3.5.1.1. Canine
16.1.3.5.1.2. Avian
16.1.3.5.1.3. Feline
16.1.3.5.2. Livestock Animals
16.1.3.5.2.1. Aquatic
16.1.3.5.2.2. Bovine
16.1.3.5.2.3. Porcine
16.1.3.5.2.4. Ovine/Caprine
16.1.3.5.2.5. Poultry
16.1.3.5.3. Equine
16.1.4. APEJ Veterinary Vaccines Market Attractiveness
16.1.4.1. By Country
16.1.4.2. By Product Type
16.1.4.3. By Diseases
16.1.4.4. By Distribution Channel
16.1.4.5. By Species Type
16.2. Drivers and Restraints Impact Analysis
17. JAPAN Veterinary Vaccines Market Analysis
17.1. Introduction
17.1.1. JAPAN Veterinary Vaccines Market Value Forecast and Y-o-Y Growth
17.1.2. JAPAN Veterinary Vaccines Market Absolute $ Opportunity
17.1.3. Market Value Forecast
17.1.3.1. By Product Type
17.1.3.1.1. Attenuated Live Vaccines
17.1.3.1.2. Conjugate Vaccines
17.1.3.1.3. Inactivated Vaccines
17.1.3.1.4. Subunit Vaccines
17.1.3.1.5. Toxoid Vaccines
17.1.3.1.6. DNA Vaccines
17.1.3.1.7. Recombinant Vaccines
17.1.3.2. By Diseases Type
17.1.3.2.1. Anaplasmosis
17.1.3.2.2. Canine Parvovirus
17.1.3.2.3. Foot & Mouth Disease
17.1.3.2.4. New Castle Disease
17.1.3.2.5. Distemper Disease
17.1.3.2.6. Influenza
17.1.3.2.7 Porcine Reproductive & Respiratory Syndrome (PRRS)
17.1.3.2.8. Others
17.1.3.3. By Distribution Channel
17.1.3.3.1. Veterinary Clinics
17.1.3.3.2. Veterinary Hospitals
17.1.3.3.3. Veterinary Research Institutes
17.1.3.3.4. Retail Pharmacies & Others
17.1.3.4. By Species Type
17.1.3.4.1. Companion Animals
17.1.3.4.1.1. Canine
17.1.3.4.1.2. Avian
17.1.3.4.1.3. Feline
17.1.3.4.2. Livestock Animals
17.1.3.4.2.1. Aquatic
17.1.3.4.2.2. Bovine
17.1.3.4.2.3. Porcine
17.1.3.4.2.4. Ovine/Caprine
17.1.3.4.2.5. Poultry
17.1.3.4.3. Equine
17.1.4. JAPAN Veterinary Vaccines Market Attractiveness
17.1.4.1. By Country
17.1.4.2. By Product Type
17.1.4.3. By Diseases
17.1.4.4. By Distribution Channel
17.1.4.5. By Species Type
17.2. Drivers and Restraints Impact Analysis
18. MEA Veterinary Vaccines Market Analysis
18.1. Introduction
18.1.1. MEA Veterinary Vaccines Market Value Forecast and Y-o-Y Growth
18.1.2. MEA Veterinary Vaccines Market Absolute $ Opportunity
18.1.3. Market Value Forecast
18.1.3.1. By Country
18.1.3.1.1. GCC Countries
18.1.3.1.2. South Africa
18.1.3.1.3. Rest of MEA
18.1.3.2. By Product Type
18.1.3.2.1. Attenuated Live Vaccines
18.1.3.2.2. Conjugate Vaccines
18.1.3.2.3. Inactivated Vaccines
18.1.3.2.4. Subunit Vaccines
18.1.3.2.5. Toxoid Vaccines
18.1.3.2.6. DNA Vaccines
18.1.3.2.7. Recombinant Vaccines
18.1.3.3. By Diseases Type
18.1.3.3.1. Anaplasmosis
18.1.3.3.2. Canine Parvovirus
18.1.3.3.3. Foot & Mouth Disease
18.1.3.3.4. New Castle Disease
18.1.3.3.5. Distemper Disease
18.1.3.3.6. Influenza
18.1.3.3.7. Porcine Reproductive & Respiratory Syndrome (PRRS)
18.1.3.3.8. Others
18.1.3.4. By Distribution Channel
18.1.3.4.1. Veterinary Clinics
18.1.3.4.2. Veterinary Hospitals
18.1.3.4.3. Veterinary Research Institutes
18.1.3.4.4. Retail Pharmacies & Others
18.1.3.5. By Species Type
18.1.3.5.1. Companion Animals
18.1.3.5.1.1. Canine
18.1.3.5.1.2. Avian
18.1.3.5.1.3. Feline
18.1.3.5.2. Livestock Animals
18.1.3.5.2.1. Aquatic
18.1.3.5.2.2. Bovine
18.1.3.5.2.3. Porcine
18.1.3.5.2.4. Ovine/Caprine
18.1.3.5.2.5. Poultry
18.1.3.5.3. Equine
18.1.4. MEA Veterinary Vaccines Market Attractiveness
18.1.4.1. By Country
18.1.4.2. By Product Type
18.1.4.3. By Diseases
18.1.4.4. By Distribution Channel
18.1.4.5. By Species Type
18.1.5. Drivers and Restraints Impact Analysis
19. Competition Landscape
19.1. Competition Dashboard
19.2. Company Profiles
19.2.1. Revenue
19.2.2. Product Types/Brand Offerings
19.2.3. Key developments
19.2.4. SWOT Analysis
19.3. Company Highlights
19.3.1. Merial
19.3.2. Zoetis
19.3.3. Elanco
19.3.4. Merck & Co. Inc
19.3.5. Borhinger Inghlem
19.3.6. Bayer Phsrms Ag
19.3.7. Ceva
19.3.8. Verbs
Table 1: Global Veterinary Vaccines Market Value, By Product Type (US$ Mn), 2015–2026
Table 2: Global Veterinary Vaccines Market Value (US$ Mn) by Diseases, 2015–2026
Table 3: Global Veterinary Vaccines Market Value (US$ Mn) By Distribution Channels, 2015–2026
Table 4: Global Veterinary Vaccines Market Value (US$ Mn) By Companion Animal Species Type, 2015–2026
Table 5: Global Veterinary Vaccines Market Value (US$ Mn) By Livestock Animal Species Type, 2015–2026
Table 6: North America Veterinary Vaccines Market Value (US$ Mn) by Country, 2015–2026
Table 7: North America Veterinary Vaccines Market Value, By Product Type (US$ Mn), 2015–2026
Table 8: North America Veterinary Vaccines Market Value (US$ Mn), 2015–2026
Table 9: North America Veterinary Vaccines Market Value (US$ Mn), 2015–2026
Table 10: North America Veterinary Vaccines Market Value (US$ Mn), 2015–2026
Table 11: North America Veterinary Vaccines Market Value (US$ Mn), 2015–2026
Table 12: Latin America Veterinary Vaccines Market Value (US$ Mn) by Country, 2015–2026
Table 13: Latin America Veterinary Vaccines Market Value, By Product Type (US$ Mn), 2015–2026
Table 14: Latin America Veterinary Vaccines Market Value (US$ Mn), 2015–2026
Table 15: Latin America Veterinary Vaccines Market Value (US$ Mn), 2015–2026
Table 16: Latin America Veterinary Vaccines Market Value (US$ Mn), 2015–2026
Table 17: Latin America Veterinary Vaccines Market Value (US$ Mn), 2015–2026
Table 18: Western Europe Veterinary Vaccines Market Value (US$ Mn) by Country, 2015–2026
Table 19: Western Europe Veterinary Vaccines Market Value, By Product Type (US$ Mn), 2015–2026
Table 20: Western Europe Veterinary Vaccines Market Value (US$ Mn), 2015–2026
Table 21: Western Europe Veterinary Vaccines Market Value (US$ Mn), 2015–2026
Table 22: Western Europe Veterinary Vaccines Market Value (US$ Mn), 2015–2026
Table 23: Western Europe Veterinary Vaccines Market Value (US$ Mn), 2015–2026
Table 24: Eastern Europe Veterinary Vaccines Market Value (US$ Mn) by Country, 2015–2026
Table 25: Eastern Europe Veterinary Vaccines Market Value, By Product Type (US$ Mn), 2015–2026
Table 26: Eastern Europe Veterinary Vaccines Market Value (US$ Mn), 2015–2026
Table 27: Eastern Europe Veterinary Vaccines Market Value (US$ Mn), 2015–2026
Table 28: Eastern Europe Veterinary Vaccines Market Value (US$ Mn), 2015–2026
Table 29: Eastern Europe Veterinary Vaccines Market Value (US$ Mn), 2015–2026
Table 30: APEJ Veterinary Vaccines Market Value (US$ Mn) by Country, 2015–2026
Table 31: APEJ Veterinary Vaccines Market Value, By Product Type (US$ Mn), 2015–2026
Table 32: APEJ Veterinary Vaccines Market Value (US$ Mn), 2015–2026
Table 33: APEJ Veterinary Vaccines Market Value (US$ Mn) By Distribution Channel, 2015–2026
Table 34: APEJ Veterinary Vaccines Market Value (US$ Mn) By Companion Animals Segment, 2015–2026
Table 35: APEJ Veterinary Vaccines Market Value (US$ Mn) By Livestock Animals Segment, 2015–2026
Table 36: MEA Veterinary Vaccines Market Value (US$ Mn) by Country, 2015–2026
Table 37: MEA Veterinary Vaccines Market Value, By Product Type (US$ Mn), 2015–2026
Table 38: MEA Veterinary Vaccines Market Value (US$ Mn), 2015–2026
Table 39: MEA Veterinary Vaccines Market Value (US$ Mn), 2015–2026
Table 40: MEA Veterinary Vaccines Market Value (US$ Mn), 2015–2026
Table 41: MEA Veterinary Vaccines Market Value (US$ Mn), 2015–2026
Table 42: Japan Veterinary Vaccines Market Value, By Product Type (US$ Mn), 2015–2026
Table 43: Japan Veterinary Vaccines Market Value (US$ Mn) By Diseases, 2015–2026
Table 44: Japan Veterinary Vaccines Market Value (US$ Mn) By Distribution Channels, 2015–2026
Table 45: Japan Veterinary Vaccines Market Value (US$ Mn) By Companion Animal Species Type, 2015–2026
Table 46: Japan Veterinary Vaccines Market Value (US$ Mn) By Livestock Animal Species Type, 2015–2026
Figure 1: Global Veterinary Vaccines Market Value (US$ Mn) & Growth Forecast, 2015–2026
Figure 2: Global Veterinary Vaccines Market Absolute $ Opportunity, 2015–2026
Figure 3: Global Veterinary Vaccines Market Value Share (%), By Product Type, 2016 & 2026
Figure 4: Global Veterinary Vaccines Market Attractiveness, By Product Type, 2015–2026
Figure 5: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Attenuated Live Vaccines Segment, 2015–2026
Figure 6: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Conjugate Vaccines Segment, 2015–2026
Figure 7: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Inactivated Vaccines Product Type, 2015–2026
Figure 8: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Subunit Vaccines Product Type, 2015–2026
Figure 9: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Toxoid Vaccines, 2015–2026
Figure 11: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Recombinant Vaccines, 2015–2026
Figure 12: Global Veterinary Vaccines Market Absolute $ Opportunity, by Attenuated Live Vaccines Segment, 2015 – 2026 (US$ Mn)
Figure 13: Global Veterinary Vaccines Market Absolute $ Opportunity, by Conjugate Vaccines, 2015 – 2026 (US$ Mn)
Figure 14: Global Veterinary Vaccines Market Absolute $ Opportunity, by Inactivated Vaccines Segment, 2015 – 2026 (US$ Mn)
Figure 15: Global Veterinary Vaccines Market Absolute $ Opportunity, by Subunit Vaccines Segment, 2015 – 2026 (US$ Mn)
Figure 16: Global Veterinary Vaccines Market Absolute $ Opportunity, by Toxoid Vaccines Segment, 2015 – 2026 (US$ Mn)
Figure 17: Global Veterinary Vaccines Market Absolute $ Opportunity, DNA Vaccines Segment, 2015 – 2026 (US$ Mn)
Figure 18: Global Veterinary Vaccines Market Absolute $ Opportunity, by Recombinant Vaccines Segment, 2015 – 2026 (US$ Mn)
Figure 19: Global Veterinary Vaccines Market Value Share (%), By Disease Type, 2016 & 2026
Figure 20: Global Veterinary Vaccines Market Attractiveness, By Disease Type, 2015–2026
Figure 21: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Anaplasmosis Disease Type, 2015–2026
Figure 23: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Foot & Mouth Disease Type, 2015–2026
Figure 24: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, Newcastle Disease Type, 2015–2026
Figure 26: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Influenza, Disease Type, 2015–2026
Figure 27: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Porcine Reproductive & Respiratory Syndrome (PRRS) Disease Type, 2015–2026
Figure 28: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Others Disease Type, 2015–2026
Figure 29: Global Veterinary Vaccines Market Absolute $ Opportunity, by Anaplasmosis Segment, 2015– 2026 (US$ Mn)
Figure 30: Global Veterinary Vaccines Market Absolute $ Opportunity, by Canine Parvovirus Segment, 2015 – 2026 (US$ Mn)
Figure 31: Global Veterinary Vaccines Market Absolute $ Opportunity, by Foot & Mouth Disease diseases Segment, 2015 – 2026 (US$ Mn)
Figure 32: Global Veterinary Vaccines Market Absolute $ Opportunity, by Newcastle Disease Segment, 2015 – 2026 (US$ Mn)
Figure 33: Global Veterinary Vaccines Market Absolute $ Opportunity, by Distemper Disease Segment, 2015 – 2026 (US$ Mn)
Figure 34: Global Veterinary Vaccines Market Absolute $ Opportunity, by Influenza Disease Segment, 2015 – 2026 (US$ Mn)
Figure 35: Global Veterinary Vaccines Market Absolute $ Opportunity, by Porcine Reproductive & Respiratory Syndrome (PRRS) Disease Segment, 2015 – 2026 (US$ Mn)
Figure 36: Global Veterinary Vaccines Market Absolute $ Opportunity, by Others Disease Segment, 2015 – 2026 (US$ Mn)
Figure 37: Global Veterinary Vaccines Market Value Share (%), By Distribution Channels, 2016 & 2026
Figure 38: Global Veterinary Vaccines Market Attractiveness, By Distribution Channels, 2015–2026
Figure 39: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, by Veterinary Clinic Segment, 2015 – 2026 (US$ Mn)
Figure 41: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, by Veterinary Research Institutes Segment, 2015 – 2026 (US$ Mn)
Figure 42: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, by Retail Pharmaciess Segment, 2015 – 2026 (US$ Mn)
Figure 43: Global Veterinary Vaccines Market Absolute $ Opportunity, by Veterinary Clinic Segment, 2015 – 2026 (US$ Mn)
Figure 44: Global Veterinary Vaccines Market Absolute $ Opportunity, by Veterinary Hospitals Segment, 2015 – 2026 (US$ Mn)
Figure 45: Global Veterinary Vaccines Market Absolute $ Opportunity, by Veterinary Research Institutes Segment, 2015 – 2026 (US$ Mn)
Figure 46: Global Veterinary Vaccines Market Absolute $ Opportunity, by Veterinary Retail Pharmaciess Segment, 2015 – 2026 (US$ Mn)
Figure 47: Global Veterinary Vaccines Market Value Share (%), By Species Type, 2016 & 2026
Figure 48: Global Veterinary Vaccines Market Attractiveness, By Species Type, 2015–2026
Figure 49: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Companion Animal Species Type, 2015–2026
Figure 51: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Equine Species Type, 2015–2026
Figure 52: Global Veterinary Vaccines Market Absolute $ Opportunity, by Companion Animal Species Type, 2015 – 2026 (US$ Mn)
Figure 53: Global Veterinary Vaccines Market Absolute $ Opportunity, by Livestock Animal Species Type, 2015 – 2026 (US$ Mn)
Figure 54: Global Veterinary Vaccines Market Absolute $ Opportunity, by Equine Species Type, 2015 – 2026 (US$ Mn)
Figure 55: Global Veterinary Vaccines Market Value Share (%), Region, 2016 & 2026
Figure 56: Global Veterinary Vaccines Market Attractiveness, By Region, 2015–2026
Figure 57: North America Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, 2015–2026
Figure 58: North America Veterinary Vaccines Market Share, By Country, 2015–2026
Figure 59: North America Veterinary Vaccines Market Value (US$ Mn), By Country, 2015–2026
Figure 60: North America Veterinary Vaccines Market Growth, By Country, 2015–2026
Figure 61: North America Veterinary Vaccines Market Share, By Product Type, 2016 & 2026
Figure 62: North America Veterinary Vaccines Market Value (US$ Mn), By Product Type, 2015–2026
Figure 63: North America Veterinary Vaccines Market Growth, By Product Type, 2015–2026
Figure 64: North America Veterinary Vaccines Market Share, By Diseases, 2015–2026
Figure 65: North America Veterinary Vaccines Market Value (US$ Mn), By Diseases, 2015–2026
Figure 66: North America Veterinary Vaccines Market Growth, By Diseases, 2015–2026
Figure 67: North America Veterinary Vaccines Market Share, By Distribution Channel, 2015–2026
Figure 68: North America Veterinary Vaccines Market Value (US$ Mn), By Distribution Channel, 2015–2026
Figure 69: North America Veterinary Vaccines Market Growth, By Distribution Channel, 2015–2026
Figure 70: North America Veterinary Vaccines Market Share, By Species, 2015–2026
Figure 71: North America Veterinary Vaccines Market Value (US$ Mn), By Species, 2015–2026
Figure 72: North America Veterinary Vaccines Market Growth, By Species, 2015–2026
Figure 73: Latin America Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, 2015–2026
Figure 74: Latin America Veterinary Vaccines Market Share, By Country, 2015–2026
Figure 75: Latin America Veterinary Vaccines Market Value (US$ Mn), By Country, 2015–2026
Figure 76: Latin America Veterinary Vaccines Market Growth, By Country, 2015–2026
Figure 77: Latin America Veterinary Vaccines Market Share, By Product Type, 2015–2026
Figure 78: Latin America Veterinary Vaccines Market Value (US$ Mn), By Product Type, 2015–2026
Figure 79: Latin America Veterinary Vaccines Market Growth, By Product Type, 2015–2026
Figure 80: Latin America Veterinary Vaccines Market Share, By Diseases, 2015–2026
Figure 81: Latin America Veterinary Vaccines Market Value (US$ Mn), By Diseases, 2015–2026
Figure 82: Latin America Veterinary Vaccines Market Growth, By Diseases, 2015–2026
Figure 83: Latin America Veterinary Vaccines Market Share, By Distribution Channel, 2015–2026
Figure 84: Latin America Veterinary Vaccines Market Value (US$ Mn), By Distribution Channel, 2015–2026
Figure 85: Latin America Veterinary Vaccines Market Growth, By Distribution Channel, 2015–2026
Figure 86: Latin America Veterinary Vaccines Market Share, By Species, 2015–2026
Figure 87: Latin America Veterinary Vaccines Market Value (US$ Mn), By Species, 2015–2026
Figure 88: Latin America Veterinary Vaccines Market Growth, By Species, 2015–2026
Figure 89: Western Europe Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, 2015–2026
Figure 90: Western Europe Veterinary Vaccines Market Share, By Country, 2015–2026
Figure 91: Western Europe Veterinary Vaccines Market Value (US$ Mn), By Country, 2015–2026
Figure 92: Western Europe Veterinary Vaccines Market Growth, By Country, 2015–2026
Figure 93: Western Europe Veterinary Vaccines Market Share, By Product Type, 2015–2026
Figure 94: Western Europe Veterinary Vaccines Market Value (US$ Mn), By Product Type, 2015–2026
Figure 95: Western Europe Veterinary Vaccines Market Growth, By Product Type, 2015–2026
Figure 96: Western Europe Veterinary Vaccines Market Share, By Diseases, 2015–2026
Figure 97: Western Europe Veterinary Vaccines Market Value (US$ Mn), By Diseases, 2015–2026
Figure 98: Western Europe Veterinary Vaccines Market Growth, By Diseases, 2015–2026
Figure 99: Western Europe Veterinary Vaccines Market Share, By Distribution Channel, 2015–2026
Figure 100: Western Europe Veterinary Vaccines Market Value (US$ Mn), By Distribution Channel, 2015–2026
Figure 101: Western Europe Veterinary Vaccines Market Growth, By Distribution Channel, 2015–2026
Figure 102: Western Europe Veterinary Vaccines Market Share, By Species, 2015–2026
Figure 103: Western Europe Veterinary Vaccines Market Value (US$ Mn), By Species, 2015–2026
Figure 104: Western Europe Veterinary Vaccines Market Growth, By Species, 2015–2026
Figure 105: Eastern Europe Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, 2015–2026
Figure 106: Eastern Europe Veterinary Vaccines Market Share, By Country, 2015–2026
Figure 107: Eastern Europe Veterinary Vaccines Market Value (US$ Mn), By Country, 2015–2026
Figure 108: Eastern Europe Veterinary Vaccines Market Growth, By Country, 2015–2026
Figure 109: Eastern Europe Veterinary Vaccines Market Share, By Product Type, 2015–2026
Figure 110: Eastern Europe Veterinary Vaccines Market Value (US$ Mn), By Product Type, 2015–2026
Figure 111: Eastern Europe Veterinary Vaccines Market Growth, By Product Type, 2015–2026
Figure 112: Eastern Europe Veterinary Vaccines Market Share, By Diseases, 2015–2026
Figure 113: Eastern Europe Veterinary Vaccines Market Value (US$ Mn), By Diseases, 2015–2026
Figure 114: Eastern Europe Veterinary Vaccines Market Growth, By Diseases, 2015–2026
Figure 115: Eastern Europe Veterinary Vaccines Market Share, By Distribution Channel, 2015–2026
Figure 116: Eastern Europe Veterinary Vaccines Market Value (US$ Mn), By Distribution Channel, 2015–2026
Figure 117: Eastern Europe Veterinary Vaccines Market Growth, By Distribution Channel, 2015–2026
Figure 118: Eastern Europe Veterinary Vaccines Market Share, By Species, 2015–2026
Figure 119: Eastern Europe Veterinary Vaccines Market Value (US$ Mn), By Species, 2015–2026
Figure 120: Eastern Europe Veterinary Vaccines Market Growth, By Species, 2015–2026
Figure 121: APEJ Veterinary Vaccines Market Value (US$ Mn) & Y-o-Y Growth (%) Forecast, 2015–2026
Figure 122: APEJ Veterinary Vaccines Market Share, By Country, 2016 & 2026
Figure 123: APEJ Veterinary Vaccines Market Value (US$ Mn), By Country, 2015–2026
Figure 124: APEJ Veterinary Vaccines Market Growth, By Country, 2015–2026
Figure 125: APEJ Veterinary Vaccines Market Share, By Product Type, 2016 & 2026
Figure 126: APEJ Veterinary Vaccines Market Value (US$ Mn), By Product Type, 2015–2026
Figure 127: APEJ Veterinary Vaccines Market Growth, By Product Type, 2015–2026
Figure 128: APEJ Veterinary Vaccines Market Share, By Diseases, 2016 & 2026
Figure 129: APEJ Veterinary Vaccines Market Value (US$ Mn), By Diseases, 2015–2026
Figure 130: APEJ Veterinary Vaccines Market Growth, By Diseases, 2015–2026
Figure 131: APEJ Veterinary Vaccines Market Share, By Distribution Channel, 2016 & 2026
Figure 132: APEJ Veterinary Vaccines Market Value (US$ Mn), By Distribution Channel, 2015–2026
Figure 133: APEJ Veterinary Vaccines Market Growth, By Distribution Channel, 2015–2026
Figure 134: APEJ Veterinary Vaccines Market Share, By Species, 2015–2026
Figure 135: APEJ Veterinary Vaccines Market Value (US$ Mn), By Species, 2015–2026
Figure 136: APEJ Veterinary Vaccines Market Growth, By Species, 2015–2026
Figure 137: MEA Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, 2015–2026
Figure 138: MEA Veterinary Vaccines Market Share, By Country, 2015–2026
Figure 139: MEA Veterinary Vaccines Market Value (US$ Mn), By Country, 2015–2026
Figure 140: MEA Veterinary Vaccines Market Growth, By Country, 2015–2026
Figure 141: MEA Veterinary Vaccines Market Share, By Product Type, 2015–2026
Figure 142: MEA Veterinary Vaccines Market Value (US$ Mn), By Product Type, 2015–2026
Figure 143: MEA Veterinary Vaccines Market Growth, By Product Type, 2015–2026
Figure 144: MEA Veterinary Vaccines Market Share, By Diseases, 2015–2026
Figure 145: MEA Veterinary Vaccines Market Value (US$ Mn), By Diseases, 2015–2026
Figure 146: MEA Veterinary Vaccines Market Growth, By Diseases, 2015–2026
Figure 147: MEA Veterinary Vaccines Market Share, By Distribution Channel, 2015–2026
Figure 148: MEA Veterinary Vaccines Market Value (US$ Mn), By Distribution Channel, 2015–2026
Figure 149: MEA Veterinary Vaccines Market Growth, By Distribution Channel, 2015–2026
Figure 150: MEA Veterinary Vaccines Market Share, By Species, 2015–2026
Figure 151: MEA Veterinary Vaccines Market Value (US$ Mn), By Species, 2015–2026
Figure 152: MEA Veterinary Vaccines Market Growth, By Species, 2015–2026
Figure 153: Japan Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, 2015–2026
Figure 154: Japan Veterinary Vaccines Market Share, By Product Type, 2016 & 2026
Figure 155: Japan Veterinary Vaccines Market Value (US$ Mn), By Product Type, 2015–2026
Figure 156: Japan Veterinary Vaccines Market Growth, By Product Type, 2015–2026
Figure 157: Japan Veterinary Vaccines Market Share, By Diseases, 2016 & 2026
Figure 158: Japan Veterinary Vaccines Market Value (US$ Mn), By Diseases, 2015–2026
Figure 159: Japan Veterinary Vaccines Market Growth, By Diseases, 2015–2026
Figure 160: Japan Veterinary Vaccines Market Share, By Distribution Channel, 2016 & 2026
Figure 161: Japan Veterinary Vaccines Market Value (US$ Mn), By Distribution Channel, 2015–2026
Figure 162: Japan Veterinary Vaccines Market Growth, By Distribution Channel, 2015–2026
Figure 165: Japan Veterinary Vaccines Market Share, By Species, 2016 & 2026
Figure 166: Japan Veterinary Vaccines Market Value (US$ Mn), By Species, 2015–2026
Figure 167: Japan Veterinary Vaccines Market Growth, By Species, 2015–2026